Articles by: Ronald Lewis

How Profitable is Ultragenyx Pharmaceutical Inc. (NasdaqGS:RARE)? Shares Return on Assets at -0.460365

In trying to determine how profitable a company is per asset dollar, we can take a look at  the firm’s Return on Assets.  Return on assets is calculated by dividing a company’s net income (usually annual income) by its total assets, and is displayed as a percentage. At the time of writing, Ultragenyx Pharmaceutical Inc. (NasdaqGS:RARE) […]

Read More